Jodi McBride, Ph.D. - Publications

Affiliations: 
Oregon National Primate Research Center Oregon Health and Science University, Portland, OR 
Area:
Gene therapy, neuroscience, neurodegeneration, Huntington's disease, RNA interference, viral vectors
Website:
http://www.ohsu.edu/xd/education/schools/school-of-medicine/academic-programs/graduate-studies/faculty/grad-studies-faculty.cfm?facultyid=770

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Liguore WA, Domire JS, Button D, Wang Y, Dufour BD, Srinivasan S, McBride JL. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31420242 DOI: 10.1016/j.ymthe.2019.07.017  1
2018 Dufour BD, McBride JL. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease. Neurobiology of Disease. PMID 30292559 DOI: 10.1016/j.nbd.2018.09.025  1
2016 Dufour BD, McBride JL. Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease. Experimental Neurology. PMID 27381424 DOI: 10.1016/j.expneurol.2016.06.028  1
2016 McBride JL, Clark RL. Stereotaxic Surgical Targeting of the Nonhuman Primate Caudate and Putamen: Gene Therapy for Huntington's Disease. Methods in Molecular Biology (Clifton, N.J.). 1382: 409-28. PMID 26611603 DOI: 10.1007/978-1-4939-3271-9_29  1
2016 Dufour BD, McBride JL. Intravascular AAV9 Administration for Delivering RNA Silencing Constructs to the CNS and Periphery. Methods in Molecular Biology (Clifton, N.J.). 1364: 261-75. PMID 26472457 DOI: 10.1007/978-1-4939-3112-5_21  1
2015 Keiser MS, Kordasiewicz H, McBride J. Gene Suppression Strategies for Dominantly Inherited Neurodegenerative Diseases: lessons from Huntington's Disease and Spinocerebellar Ataxia. Human Molecular Genetics. PMID 26503961 DOI: 10.1093/hmg/ddv442  0.48
2015 Pitzer M, Lueras J, Warden A, Weber S, McBride J. Viral vector mediated expression of mutant huntingtin in the dorsal raphe produces disease-related neuropathology but not depressive-like behaviors in wildtype mice. Brain Research. 1608: 177-90. PMID 25732261 DOI: 10.1016/j.brainres.2015.02.027  1
2014 Monteys AM, Spengler RM, Dufour BD, Wilson MS, Oakley CK, Sowada MJ, McBride JL, Davidson BL. Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain. Nucleic Acids Research. 42: 13315-27. PMID 25332397 DOI: 10.1093/nar/gku979  1
2014 Dufour BD, Smith CA, Clark RL, Walker TR, McBride JL. Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 797-810. PMID 24390280 DOI: 10.1038/mt.2013.289  1
2012 Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Human Molecular Genetics. 21: 406-20. PMID 21997870 DOI: 10.1093/hmg/ddr475  1
2011 McBride JL, Pitzer MR, Boudreau RL, Dufour B, Hobbs T, Ojeda SR, Davidson BL. Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 2152-62. PMID 22031240 DOI: 10.1038/mt.2011.219  1
2009 Hadaczek P, Forsayeth J, Mirek H, Munson K, Bringas J, Pivirotto P, McBride JL, Davidson BL, Bankiewicz KS. Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Human Gene Therapy. 20: 225-37. PMID 19292604 DOI: 10.1089/hum.2008.151  0.36
2009 Boudreau RL, McBride JL, Martins I, Shen S, Xing Y, Carter BJ, Davidson BL. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1053-63. PMID 19240687 DOI: 10.1038/mt.2009.17  1
2009 Ramaswamy S, McBride JL, Han I, Berry-Kravis EM, Zhou L, Herzog CD, Gasmi M, Bartus RT, Kordower JH. Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease. Neurobiology of Disease. 34: 40-50. PMID 19150499 DOI: 10.1016/j.nbd.2008.12.005  1
2008 Coryell MW, Wunsch AM, Haenfler JM, Allen JE, McBride JL, Davidson BL, Wemmie JA. Restoring Acid-sensing ion channel-1a in the amygdala of knock-out mice rescues fear memory but not unconditioned fear responses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13738-41. PMID 19091964 DOI: 10.1523/JNEUROSCI.3907-08.2008  1
2008 McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL, Burstein H, Peluso RW, Polisky B, Carter BJ, Davidson BL. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proceedings of the National Academy of Sciences of the United States of America. 105: 5868-73. PMID 18398004 DOI: 10.1073/pnas.0801775105  1
2007 Ramaswamy S, McBride JL, Kordower JH. Animal models of Huntington's disease. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 48: 356-73. PMID 17712222  1
2007 Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, Lee SK, Shankar P, Manjunath N. Transvascular delivery of small interfering RNA to the central nervous system. Nature. 448: 39-43. PMID 17572664 DOI: 10.1038/nature05901  1
2007 Ramaswamy S, McBride JL, Herzog CD, Brandon E, Gasmi M, Bartus RT, Kordower JH. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease. Neurobiology of Disease. 26: 375-84. PMID 17336076 DOI: 10.1016/j.nbd.2007.01.003  1
2006 McBride JL, Ramaswamy S, Gasmi M, Bartus RT, Herzog CD, Brandon EP, Zhou L, Pitzer MR, Berry-Kravis EM, Kordower JH. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 9345-50. PMID 16751280 DOI: 10.1073/pnas.0508875103  1
2004 McBride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, Svendsen CN, Kordower JH. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. The Journal of Comparative Neurology. 475: 211-9. PMID 15211462 DOI: 10.1002/cne.20176  1
2003 McBride JL, During MJ, Wuu J, Chen EY, Leurgans SE, Kordower JH. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Experimental Neurology. 181: 213-23. PMID 12781994 DOI: 10.1016/S0014-4886(03)00044-X  1
2002 McBride JL, Kordower JH. Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF. Progress in Brain Research. 138: 421-32. PMID 12432782 DOI: 10.1016/S0079-6123(02)38091-9  1
2000 Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (New York, N.Y.). 290: 767-73. PMID 11052933 DOI: 10.1126/science.290.5492.767  1
Show low-probability matches.